Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori

NCT04850209
completednot_applicable

Individual vs Cohort Long Distance Advising for Mental Care for Congenital Cataract Guardians

NCT03216655
completednot_applicable

Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients

NCT03567226

Clinical Trials (3)

Showing 3 of 3 trials
NCT04850209Not Applicable

The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori

Completed
NCT03216655Not Applicable

Individual vs Cohort Long Distance Advising for Mental Care for Congenital Cataract Guardians

Completed
NCT03567226Not Applicable

Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3